-
J. Edward Moreno
Posts
Walmart gives disappointing Q2 guidance after Q1 results hit estimates
The retailer reported earnings before the bell on Thursday.
The Enhanced Games isn’t just about sports — it’s a $31 million product demo
Inside the cash-burning, uninsurable, and controversial plan to turn a pro-doping sporting event into a mainstream supplement empire.
Doximity sinks on gloomy full-year revenue outlook, says AI compute costs are weighing on margins
The company reported earnings results on Wednesday.
Hims enters a “strategic pivot” following blowback from its copycat Wegovy pill
After selling compounded GLP-1 drugs for two years, Hims is launching an expensive shift to branded treatments.
Hims reports revenue miss and surprise loss in Q1
The company reported earnings results on Monday.
Lumentum jumps on Nasdaq-100 Index inclusion
The stock rose 4.8% in premarket trading by 6 a.m. ET.
Investors really want Moderna to whip up a hantavirus vaccine
The company told Bloomberg it is in the early stages of researching vaccines to protect against hantaviruses.
McDonald’s Q1 results come in above Wall Street estimates
The company reported earnings results on Thursday.
Snap ends Perplexity deal, says advertising business took a hit from “geopolitical headwinds” in Q1
The company reported earnings results on Wednesday.
Oscar Health beats Q1 estimates on lower medical costs, reaffirms full-year guidance
The company reported earnings results on Wednesday.